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Edited by Hans-Dieter KlenkAbstract A recombinant D92G mutant sialidase from Micro-
monospora viridifaciens has been cloned, expressed and puriﬁed.
Kinetic studies reveal that the replacement of the conserved
aspartic acid with glycine results in a catalytically competent
retaining sialidase that possesses signiﬁcant activity against
activated substrates. The contribution of this aspartate residue to
the free energy of hydrolysis for natural substrates is greater
than 19 kJ/mol. The three dimensional structure of the D92G
mutant shows that the removal of aspartic acid 92 causes no
signiﬁcant re-arrangement of the active site, and that an ordered
water molecule substitutes for the carboxylate group of D92.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Sialidases (N-acetylneuraminosyl glycohydrolase, neur-
aminidase, EC 3.2.1.18) belong to a family of exoglycosidases
[1] and some of these enzymes are involved in the pathogenesis
of several diseases [2,3]. Sialidases and trans-sialidases contain
seven strictly conserved amino acids [4–10], namely: (a) an
arginine triad which binds to the carboxylate group of the
substrate via electrostatic interactions; (b) a distal glutamate
residue which forms a salt bridge with one of the conserved
arginine residues; and (c) three residues that are important for
catalysis, a tyrosine–glutamic acid dyad and an aspartic acid.
All known natural sialidases catalyze the hydrolysis of sub-
strates with retention of anomeric conﬁguration [11], an obser-
vation that is compatible with this family of enzymes operating
via a standard double displacement mechanism [11–16]. Re-
cently, Watson et al. [17] showed that three separate tyrosine
mutants of the enzyme from Micromonospora viridifaciens are
inverting sialidases. Such an observation is evidence for the* Corresponding authors. Fax: +44-1334-462595 (G. Taylor), +1-604-
291-3765 (A.J. Bennet).
E-mail addresses: glt2@st-and.ac.uk (G. Taylor), bennet@sfu.ca (A.J.
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Abbreviations: MU-aNeu5Ac, 4-methylumbelliferyl a-D-N-acetylneu-
raminide
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.10.016conserved tyrosine residue being the catalytic nucleophile in
typical sialidases and that water acts as the nucleophile in the
inverting mutant enzymes by occupying the ‘‘hole’’ created
when the tyrosine is replaced by a smaller amino acid. Watts
et al. [18,19] also concluded that tyrosine is the nucleophile in
trans-sialidases by showing that a mutant enzyme becomes co-
valentlymodiﬁed on the active-site tyrosine during turnover of a
ﬂuorinated substrate analog. Accordingly, the presumed role of
the glutamate residue of the catalytic dyad is to facilitate nu-
cleophilic attack of the tyrosine by acting as a general-base.
With regard to the third catalytic residue, namely the con-
served aspartic acid, it has been proposed that its role is to act
as a general acid catalyst [20]. The results from previous mu-
tagenic studies on this aspartic acid residue led to the conclu-
sion that it is important for catalysis, but its speciﬁc energetic
contribution to the catalysis was not delineated [21–23].
The present paper details a series of kinetic and product
studies that were performed on the D92G mutant of
M. viridifaciens sialidase using a variety of substituted aryl a-D-
N-acetylneuraminides (1) and two natural substrate analogs,
30-sialyllactose (2) and 60-sialyllactose (3). In addition, in order
to understand any structural implications mutating the as-
partic acid to a glycine might have on the integrity of the active
site, the three dimensional structures of the D92G mutant in
the apo form and complexed with the inhibitor 2-deoxy-2,3-
dehydro-N-acetylneuraminic acid (Neu5Ac2en, DANA), a
compound believed to mimic the reaction transition state, were
studied using X-ray crystallography.
2. Materials and methods
2.1. Materials
All restriction endonucleases and DNA modiﬁcation enzymes were
purchased from Gibco BRL or New England BioLabs (Beverly, MA).
All DNA manipulations were carried out according to standardblished by Elsevier B.V. All rights reserved.
Table 1
Data collection and crystallographic analysis
Crystal D92G D92G+Neu5Ac2en
X-ray source ESRF ID14-2 in-house
Measured reﬂections 1 060 418 175 360
Unique reﬂections 82 427 44 772
Maximum resolution (A) 1.70 (1.79–1.70) 2.10 (2.20–2.10)
Completeness (%) 92 (72) 89 (88)
R-merge 0.070 (0.32) 0.068 (0.30)
Reﬁnement
Resolution range (A) 87–1.70 87–2.10
R-factor 0.163 0.166
266 J.N. Watson et al. / FEBS Letters 577 (2004) 265–269procedures [24]. All chemicals were of analytical grade or better and
were purchased from Sigma–Aldrich unless otherwise noted.
Site-directed mutagenesis – Mutagenesis was performed according to
the previously described strategy, using the pJWHS2 plasmid as the
template for the sialidase gene [17]. Reverse mutagenic primers were
D92G-R0 (50-GGGCGCGCCGATACCGGTCG-30), D92A-R0 (50-
GGGCGCGGCGATACCGGTCG-30), and D92S-R0 (50-CGGG-
CGCGGAGATACCGGTCG-30) (codon substitution is underlined).
Forward mutagenic primer sequences were D92G-F0 (50-GTA-
TCGGCGCGCCCGGCCC-30), D92A-F0 (50-GTATCGCCGCGC-
CCGGCCC-30), andD92S-F0 (50-GT-ATCTCCGCGCCCGGCCC-30).
Restriction and DNA sequence analysis was used to conﬁrm the three
separate D92 mutations, as well as to ensure that spurious mutations
had not occurred during DNA manipulation.R-free 0.198 0.219
RMS bond lengths (A) 0.02 0.021
RMS bond angles () 1.84 1.77
Number of proteins atoms 4568 4555
Number of waters 711 519
Number of ligand atoms 56 33
Figures in parentheses refer to the highest resolution shell of data.2.2. Enzyme puriﬁcation and kinetics
The sialidase variants D92G, D92A and D92S were expressed in a
manner identical to that reported for the wild-type enzyme, and pu-
riﬁcation of the D92G mutant and all kinetic experiments followed the
previously described protocols [17].2.3. Crystallization and X-ray data collection
The puriﬁed protein was concentrated to 20 mg ml1 in 20 mM
sodium phosphate, pH 7.0, and crystallized using the sitting drop va-
por diﬀusion method. Crystals appeared within one week at 293 K in
drops composed of 2 ll protein solution plus 2 ll of mother liquor
containing 13% (w/w) PEG 3350 and 0.2 M ammonium citrate. The
complex with Neu5Ac2en was obtained by soaking the crystals in 20
mM Neu5Ac2en for 2 h at 293 K. Crystals were cryoprotected with
10% w/v glycerol in the crystallization buﬀer for one minute prior to
ﬂash freezing in a nitrogen stream at 100 K. Diﬀraction data were
collected on the ESRF beamline ID14.2, for the apo structure, and on
a Rigaku/MSC MircoMax 007 rotating anode generator, for the
Neu5Ac2en complex. All data were processed using MOSFLM [25]
and other programs from the CCP4 suite [26]. The crystals belong to
space group P212121, with one molecule in the asymmetric unit. Cell
dimensions were a ¼ 46:6 A, b ¼ 110:35 A, and c ¼ 141:88 A for the
unliganded enzyme, and a ¼ 46:6 A, b ¼ 111:61 A, and c ¼ 143:87 A
for the Neu5Ac2en complex. Data statistics are given in Table 1.2.4. Structure solution
The starting model for crystallographic reﬁnement was the 2.5 A
structure of the M. viridifaciens sialidase reported previously [7], PDB
code 1EUU, which was in a monoclinic P21 unit cell. A molecular
replacement solution in the new orthorhombic cell for the apo struc-
ture was found using the complete model with AMoRe [27]. Rigid
body reﬁnement of the three domains (residues 47–402, 403–502 and
503–647) was followed by restrained reﬁnement using REFMAC5 [28],
with iterative cycles of model building in the program O. Solvent
molecules were added automatically using the program ARP/wARP
[29] and visually inspected for correct placement in O [30]. The ﬁnal
crystallographic statistics are given in Table 1. The apo structure re-
vealed lactose bound to the galactose-binding domain via its galactose,
and the active site occupied by a citrate and glycerol. The Neu5Ac2en
complex revealed the inhibitor bound to the active site and the ga-
lactose-binding domain occupied by an ordered galactose.
Atomic coordinates have been deposited with the Protein Databank
with codes 1W8O and 1W8N for the D92G apo and D92G Neu5A-
c2en complex, respectively.Fig. 1. Eﬀect of temperature on the relative rates of sialidase-catalyzed
hydrolysis of MU-aNeu5Ac at pH 5.25 for the wild-type enzyme (s)
and D92G mutant (d). Data for wild-type reproduced with permission
of the American Chemical Society.3. Results and discussion
3.1. Mechanism utilized by mutants of the conserved aspartic
acid
Three separate mutants of the conserved aspartic acid of the
M. viridifaciens sialidase were produced recombinantly in an
Escherichia coli expression system. These variants (D92G,
D92A and D92S) were expressed at levels similar to the wild-
type enzyme. Moreover, the supernatants for the expression of
all three mutants displayed a comparable catalytic activity tothat of the native enzyme using the substrate MU-aNeu5Ac.
The puriﬁed D92G mutant was selected for detailed mecha-
nistic and structural investigation because it was the most ac-
tive mutant. The thermostability proﬁles of this mutant and
the wild-type enzyme are shown in Fig. 1.
Fig. 2 shows a graphical representation of the time course
for D92G mutant-catalyzed hydrolysis of MU-aNeu5Ac
monitored by 1H NMR spectroscopy. Thus, the D92G mutant
and the wild-type [17] sialidases display homologous mecha-
nistic traits in that both catalyze substrate hydrolysis with re-
tention of anomeric conﬁguration. Therefore, it can be
concluded that the D92G mutant-catalyzed reaction is oper-
ating via a double displacement mechanism in which the
conserved tyrosine residue (Y370) is acting nucleophilically.
Also, the D92G mutant is remarkably active, for example,
using the ﬂuorogenic substrate MU-aNeu5Ac, its measured
kcat=Km value is 82% of that for the wild-type enzyme.
3.2. Contributions of the aspartic acid residue to catalysis
An obvious question that needs answering is: what is the
function of the aspartic acid if its removal results in a cata-
lytically active enzyme? The data summarized in Table 2
show that a pronounced change in relative catalytic activity
occurs between the wild-type and the D92G mutant sialidases
Fig. 2. Mole fractions of substrate and products monitored over time
for the D92G mutant-catalyzed hydrolysis of MU-aNeu5Ac. Values
were calculated using the relative integrals of the H3eq signals of MU-
aNeu5Ac (h), aNeu5Ac (d) and bNeu5Ac (s).
Fig. 3. Brønsted plots. Eﬀect of leaving group ability on kcat (d) and
kcat/Km ðsÞ for the D92G mutant sialidase at 37 C and a pH of 5.25.
Leaving group ability represented as pKa (BHþ) is as follows: 4-ni-
trophenol (7.18); 4-methylumbelliferone (7.80); 4-cyanophenol (7.96);
3-nitrophenol (8.27); 3-chlorophenol (9.09); 3-methoxyphenol (9.60);
phenol (9.92); and lactose (30-OH (13.6) and 60-OH (13.8)). The
experimental points for the enzyme-catalyzed hydrolysis of the 3-
methoxyphenyl substrate (m kcat; and n kcat/Km) are omitted from the
displayed best ﬁt lines.
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In detail, Fig. 3 displays the Brønsted plots for the D92G
mutant sialidase-catalyzed hydrolysis reactions. The derived
blg parameters are )0.37 0.02 and )0.72 0.03 for the ki-
netic terms kcat and kcat=Km, respectively. For the wild-type
sialidase-catalyzed reaction, kcat is limited by a step(s) that
occurs after cleavage of the glycosidic bond [17], a similar
ﬁnding has been reported for type A inﬂuenza virus sialidase
[31], and this step likely involves a conformational change
[32]. Substitution of the conserved aspartic acid by a glycine
residue results in glycosidic bond cleavage becoming partially
rate-limiting for kcat. That is, the ﬁrst-order rate constants for
reaction of the Michaelis complex (kcat) are inﬂuenced by the
leaving group ability (blg ¼ 0:37). As a result, it can be
concluded that the transition state for D92G mutant-
catalyzed cleavage of the glycosidic bond in natural substrate
analogs (2 and 3) is at least 19 kJ/mol higher in energy (DDGz
at 37 C) than the corresponding transition state for the wild-
type sialidase reaction. A similar conclusion can be made
concerning the kinetic parameter kcat=Km, where the blg value
increases from )0.30 (wild-type) to )0.72 (D92G). In other
words, the conserved aspartic acid residue displays a greater
catalytic eﬀect when the substrate possesses a bad leaving
group, such as lactose, one of the natural aglycons. It is ex-
pected that a similar eﬀect would be observed with all natural
sialosides, including glycolipids and glycoproteins, given thatTable 2
Relative catalytic activity of the wild-type and the D92G mutant
sialidases
Leaving group Relative kcat
a Relative kcat/Km
b
4-Nitrophenol 7.8 1.5
4-Methylumbelliferone 4.4 1.2
30-Lactose 1.5 103 1.6 103
60-Lactose 2.3 103 2.6 102
a Equals kcat(wild-type)/kcat(D92G).
b Equals kcat=Km(wild-type)/kcat=Km(D92G).
Fig. 4. Eﬀect of pH on kinetic parameters for wild-type (s) and mu-
tant D92G (d). (A) The pH dependence of kcat and (B) the pH de-
pendence of kcat=KM. All kinetic parameters were determined at 37 C,
using MU-aNeu5Ac as the substrate. Data for wild-type reproduced
with permission of the American Chemical Society.
Fig. 5. Superimposition of the active site residues of wild-type catalytic domain with Neu5Ac2en (PDB 1EUS) and the D92G-Neu5Ac2en complex.
Residues of the wild-type structure are shown in slate and of the mutant in wheat. The hydrogen bonding interactions are drawn as green dotted lines;
the interaction of Asp92 with Asp85 is shown in orange.
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unit.
3.3. Eﬀect of pH on the catalytic activity of the D92G mutant
The pH-rate proﬁles for the catalyzed hydrolysis of MU-
aNeu5Ac by the D92G mutant and wild-type sialidases are
strikingly similar at all pH values above 5 (Fig. 4). These ob-
servations are consistent with the phenoxide leaving group re-
quiring little acid-catalysis for departure [33]. However, at low
pH both the kcat and kcat=Km values for the D92G mutant-
catalyzed hydrolysis of MU-aNeu5Ac level oﬀ, while for the
wild-type reactions the corresponding rate constants decrease
(Fig. 4). Thus, it appears that protonation of an enzymatic res-
idue slows down the rate-limiting step for thewild-type sialidase,
which is presumed to be a conformational change, yet theD92G
mutant enzyme displays no evidence for such a titration.
3.4. Crystal structure of the D92G mutant
The crystal structure of the D92G mutant shows that the
substitution of the conserved aspartic acid to a more ﬂexible
glycine caused no signiﬁcant perturbation of the active site (rms
ﬁt of 0.43 A for Ca 47–402 of the catalytic domain in com-
parison to the wild type structure, pdb code 1EUU), and in
particular, no movement of the loop that contains D92. In-
terestingly, the M. viridifaciens sialidase is one of the only two
bacterial sialidases where this aspartic acid forms a direct hy-
drogen bond to the O4 of the ligand (2.7A), the other one being
Vibrio cholerae sialidase whose equivalent aspartic acid is D62
(pdb code 1KIT). In the wild-type M. viridifaciens structure,
D92 also interacts with NH1 and NH2 of R87 (2.7 and 2.8 A).
In the D92G-Neu5Ac2en complex, there is no change in the
position of the ligand in comparison with the wild-type cata-lytic domain structure, pdb code 1EUS. However, as can be
seen in Fig. 5, in the D92G structure a water molecule (W41)
sits at a point between the oxygens of the carboxylate group of
D92 in the wild-type structure, and forms hydrogen bonds with
O4 of Neu5Ac2en (3.2 A) and NH1 of R87 (2.9 A).
Given the similarity of the crystallographic models (Fig. 5),
it is not readily apparent what structural change gives rise to
the diﬀerent kinetic behavior at low pH values. However, it
does appear that removal of aspartic acid 92 could lower the
pKa of aspartic acid 85, since they are communicating with
each other via arginine 87 (Fig. 5). This hypothesis can be
tested by making mutations at these non-conserved H-bonding
residues.
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